Amanda Jacobson

1.0k total citations
19 papers, 467 citations indexed

About

Amanda Jacobson is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Amanda Jacobson has authored 19 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Genetics and 6 papers in Hematology. Recurrent topics in Amanda Jacobson's work include Chronic Lymphocytic Leukemia Research (7 papers), Complement system in diseases (4 papers) and Immune Cell Function and Interaction (3 papers). Amanda Jacobson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Complement system in diseases (4 papers) and Immune Cell Function and Interaction (3 papers). Amanda Jacobson collaborates with scholars based in United States, Australia and Switzerland. Amanda Jacobson's co-authors include John H. Weis, Samuel B. Ho, Janis J. Weis, Mark R. Frey, Laurie L. Shekels, Helen Horton, L Dvorák, D. Brent Polk, Soren Gantt and Heather B. Jaspan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Amanda Jacobson

19 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Jacobson United States 11 215 134 63 58 58 19 467
Mildred Kwan United States 11 291 1.4× 207 1.5× 48 0.8× 28 0.5× 36 0.6× 19 517
Iris Schäfer Germany 12 357 1.7× 96 0.7× 66 1.0× 83 1.4× 62 1.1× 16 579
Emma Hamilton United States 14 80 0.4× 109 0.8× 38 0.6× 66 1.1× 97 1.7× 23 501
I Janatková Czechia 13 153 0.7× 77 0.6× 53 0.8× 23 0.4× 47 0.8× 32 412
Ayumu Ito Japan 12 129 0.6× 110 0.8× 34 0.5× 45 0.8× 163 2.8× 50 438
Marie Thérèse Rubio France 14 224 1.0× 129 1.0× 25 0.4× 27 0.5× 182 3.1× 39 561
W. Craig Hooper United States 15 192 0.9× 104 0.8× 22 0.3× 45 0.8× 64 1.1× 34 522
Mary Guckian United Kingdom 10 209 1.0× 111 0.8× 36 0.6× 22 0.4× 77 1.3× 13 465
Fusayuki Omori Japan 13 177 0.8× 106 0.8× 37 0.6× 23 0.4× 114 2.0× 36 458
Masahiro Yasui Japan 12 122 0.6× 72 0.5× 26 0.4× 58 1.0× 145 2.5× 40 404

Countries citing papers authored by Amanda Jacobson

Since Specialization
Citations

This map shows the geographic impact of Amanda Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Jacobson more than expected).

Fields of papers citing papers by Amanda Jacobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Jacobson. The network helps show where Amanda Jacobson may publish in the future.

Co-authorship network of co-authors of Amanda Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Jacobson. A scholar is included among the top collaborators of Amanda Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Jacobson. Amanda Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ma, Shuo, John F. Seymour, Danielle M. Brander, et al.. (2021). Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy. Blood. 138(10). 836–846. 24 indexed citations
2.
Handunnetti, Sasanka M., Mary Ann Anderson, Andrew W. Roberts, et al.. (2021). Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. SHILAP Revista de lepidopterología. 2(2). 266–271. 3 indexed citations
3.
Lacayo, Norman J., Vinod Pullarkat, Wendy Stock, et al.. (2019). Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Blood. 134(Supplement_1). 285–285. 21 indexed citations
4.
Brander, Danielle M., John F. Seymour, Thomas J. Kipps, et al.. (2019). Durability of Responses on Continuous Therapy and Following Drug Cessation with Venetoclax and Rituximab: Long-Term Follow-up Analysis of a Phase 1b Study in Patients with Relapsed CLL. Blood. 134(Supplement_1). 3036–3036. 12 indexed citations
5.
Chyla, Brenda, Relja Popovic, Charles Lu, et al.. (2019). Identification of Recurrent Genomic Alterations in the Apoptotic Machinery in CLL Patients Treated with Venetoclax Monotherapy. Blood. 134(Supplement_1). 172–172. 3 indexed citations
6.
Jabbour, Elias, Charles G. Mullighan, Vinod Pullarkat, et al.. (2019). Combination BCL-2 Inhibitor Therapy with Venetoclax and Navitoclax in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19. S184–S185. 1 indexed citations
7.
Alexander, Thomas, Norman J. Lacayo, Vinod Pullarkat, et al.. (2018). Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Blood. 132(Supplement 1). 3966–3966. 3 indexed citations
8.
Gervassi, Ana, Sandra Dross, Amanda Jacobson, et al.. (2014). Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses. PLoS ONE. 9(9). e107816–e107816. 73 indexed citations
9.
Jacobson, Amanda, et al.. (2013). Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity. PLoS ONE. 8(6). e67700–e67700. 19 indexed citations
10.
Cachola, Leslie M., Marco Garcia, Regina Jihea Ahn, et al.. (2012). Asthma Discordance in Twins Is Linked to Epigenetic Modifications of T Cells. PLoS ONE. 7(11). e48796–e48796. 72 indexed citations
11.
Roundy, Kirstin M., et al.. (2010). The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors. European Journal of Immunology. 40(4). 1139–1149. 10 indexed citations
12.
Jacobson, Amanda, Kirstin M. Roundy, Janis J. Weis, & John H. Weis. (2009). Regulation of Murine Splenic B Cell CR3 Expression by Complement Component 3. The Journal of Immunology. 183(6). 3963–3970. 17 indexed citations
13.
Jacobson, Amanda, et al.. (2009). CD21 signaling via C3 regulates Purkinje cell protein 4 expression. Molecular Immunology. 46(7). 1488–1493. 6 indexed citations
14.
Jacobson, Amanda & John H. Weis. (2008). Comparative Functional Evolution of Human and Mouse CR1 and CR2,. The Journal of Immunology. 181(5). 2953–2959. 66 indexed citations
15.
Jacobson, Amanda, Janis J. Weis, & John H. Weis. (2008). Complement Receptors 1 and 2 Influence the Immune Environment in a B Cell Receptor-Independent Manner. The Journal of Immunology. 180(7). 5057–5066. 15 indexed citations
16.
Jacobson, Amanda, et al.. (2007). Mice Lacking CD21 and CD35 Proteins Mount Effective Immune Responses againstBorrelia burgdorferiInfection. Infection and Immunity. 75(4). 2075–2078. 2 indexed citations
17.
Ho, Samuel B., L Dvorák, Amanda Jacobson, et al.. (2006). Cysteine-Rich Domains of Muc3 Intestinal Mucin Promote Cell Migration, Inhibit Apoptosis, and Accelerate Wound Healing. Gastroenterology. 131(5). 1501–1517. 87 indexed citations
18.
Ho, Samuel B., Ann Hyslop, Richard Albrecht, et al.. (2004). Quantification of Colorectal Cancer Micrometastases in Lymph Nodes by Nested and Real-Time Reverse Transcriptase-PCR Analysis for Carcinoembryonic Antigen. Clinical Cancer Research. 10(17). 5777–5784. 28 indexed citations
19.
Шерман, Л. А., et al.. (1977). Quantitation of the Reticuloendothelial System Clearance of Soluble Fibrin. British Journal of Haematology. 37(2). 231–238. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026